ArticleBlood cancer discovery2022

Dnmt3a-Mutant Hematopoietic Stem Cell Rewire IFNγ Signaling to Gain Clonal Advantage.

Marco De Dominici et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.